期刊文献+

丙型肝炎病毒传播分子流行病学诊断技术研究进展 被引量:5

Recent advances in molecular epidemiological methods for analyzing hepatitis C virus transmission
原文传递
导出
摘要 丙型肝炎病毒(hepatitis C virus,HCV)感染是导致肝硬化和肝癌发生的主要病原体之一。HCV的准种构成及病毒进化十分复杂,深入分析HCV准种构成是研究HCV传播机制的重要手段。HCV高变区(hypervariable region,HVR)是编码E1、E2/NS2的区域,该区域变异率很高,利用先进的测序技术和生物信息分析方法来分析HCV HVR准种构成,可深入了解HCV的传染来源、传播路径和进化程度。目前应用于HCV HVR准种分析的技术包括一代、二代和三代测序法及不同的生物学软件,国际上已广泛应用于HCV暴发调查溯源分析,尤其是医源性传播。当丙肝疫情发生时,通过新一代测序技术和生物学信息分析方法来进行病例溯源研究和传播路线分析,可为丙肝防控和治疗提供科学依据。 Hepatitis C virus (HCV) infection is one of the main reasons causing liver cirrhosis and hepatoeellular careinoma. The quasispecies eomposition and the evolution of HCV are very complicated. An in-depth analysis of the quasispecies composition of HCV is eritical for elucidating the mechanisms of HCV transmission. The regions encoding the envelope glyeoproteins (E1 and E2) and the nonstructural protein 2 (NS2) are hyper variable regions (HVR). Analyzing the quasispecies of HCV HVR with advanced sequen- cing and bio-information technologies would be beneficial for understanding the sources of HCV infection, the routes of transmission and the evolution of HCV. Currently, three generations of sequencing methods and some bio-information soft-wares are available for analyzing HCV HVR quasispecies. When an outbreak of HCV infection happens, using the new generation of sequencing and bio-information methods to seek the first ease and, the routes of transmission would provide scientific basis for the prevention and treatment of HCV in- fection.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2016年第10期779-782,共4页 Chinese Journal of Microbiology and Immunology
基金 国家科技部传染病“十二五”重大专项课题(2012ZX10002-005-001)
关键词 丙型肝炎病毒 传播 准种 高变区 分子流行病学 Hepatitis C Virus Transmission Quasispecies Hypervariable region Molecular epidemiology
  • 相关文献

参考文献2

二级参考文献74

  • 1[1]Global burden of disease (GBD) for hepatitis C.J Clin Pharmacol 2004; 44:20-29
  • 2[2]Shepard CW,Finelli L,Fiore AE,Bell BP.Epidemiology of hepatitis B and hepatitis B virus infection in United States children.Pediatr Infect Dis J 2005; 24:755-760
  • 3[3]Frank C,Mohamed MK,Strickland GT,Lavanchy D,Arthur RR,Magder LS,El Khoby T,Abdel-Wahab Y,Aly Ohn ES,Anwar W,Sallam I.The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt.Lancet 2000; 355:887-891
  • 4[4]Perz JF,Armstrong GL,Farrington LA,Hutin YJ,Bell BP.The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.J Hepatol 2006; 45:529-538
  • 5[5]Alter MJ,Hutin YJ,Armstrong GL.Epidemiology of hepatitis C.In:Liang TJ,Hoofnagle JH,editors.Hepatitis C.San Diego:Academic Press,2000:169-183
  • 6[6]Alter MJ,Kruszon-Moran D,Nainan OV,McQuillan GM,Gao F,Moyer LA,Kaslow RA,Margolis HS.The prevalence of hepatitis C virus infection in the United States,1988 through 1994.N Engl J Med 1999; 341:556-562
  • 7[7]Armstrong GL,Wasley A,Simard EP,McQuillan GM,Kuhnert WL,Alter MJ.The prevalence of hepatitis C virus infection in the United States,1999 through 2002.Ann Intern Med 2006; 144:705-714
  • 8[8]Law MG,Dore GJ,Bath N,Thompson S,Crofts N,Dolan K,Giles W,Gow P,Kaldor J,Loveday S,Powell E,Spencer J,Wodak A.Modelling hepatitis C virus incidence,prevalence and long-term sequelae in Australia,2001.Int J Epidemiol 2003;32:717-724
  • 9[9]Alter MJ.Prevention of spread of hepatitis C.Hepatology 2002;36:S93-S98
  • 10[10]Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease.Centers for Disease Control and Prevention.MMWR Recomm Rep 1998; 47:1-39

共引文献370

同被引文献45

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部